Arkolith/Insider Trading/RLMD/Form 4

Shenouda Maged

Chief Financial OfficerRELMADA THERAPEUTICS, INC. (RLMD) · full profile →Form 4 · filed Sep 11, 2024
Net Buying
Open-Market Buys
$150K
Open-Market Sells
$0
Net Open-Market Flow
$150K
Transactions
3
3 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Sep 11, 2024Buy(P)24K$2.95$71K88K
Sep 10, 2024Buy(P)21K$2.73$58K64K
Sep 9, 2024Buy(P)8K$2.55$21K43K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001213900-24-077792) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML